1. Abdalla AO, Hansson L, Eriksson I, Nasman-Glaser B, Mellstedt H, Osterborg A. Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients. Eur J Haematol. 2007a;79(5):371–81.
2. Abdalla AO, Hansson L, Eriksson I, et al. Idiotype protein vaccination in combination with adjuvant cytokines in patients with multiple myeloma – evaluation of T-cell responses by different read-out systems. Haematologica. 2007b;92(1):110–4.
3. Abdalla AO, Kokhaei P, Hansson L, Mellstedt H, Osterborg A. Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC). Ann Oncol. 2008;19(6):1172–9.
4. Barrios Y, Cabrera R, Yanez R, et al. Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma. Haematologica. 2002;87(4):400–7.
5. Bendandi M, Gocke CD, Kobrin CB, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [see comments]. Nat Med. 1999;5(10):1171–7.